# A Study of Persons With Gout Who Do Not Respond to or Are Allergic to Conventional Therapy

> **NCT00080210** · PHASE2 · COMPLETED · sponsor: **Savient Pharmaceuticals** · enrollment: 40 (—)

## Conditions studied

- Gout

## Interventions

- **DRUG:** Puricase

## Key facts

- **NCT ID:** NCT00080210
- **Lead sponsor:** Savient Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** —
- **Final completion:** 2005-02
- **Target enrollment:** 40 (—)
- **Last updated:** 2013-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00080210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00080210, "A Study of Persons With Gout Who Do Not Respond to or Are Allergic to Conventional Therapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00080210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*